Advertisement
Submitted paper| Volume 18, ISSUE 4, P495-503, December 1997

In-process cell counts during preparation of platelet concentrates from buffy coats

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      To ensure the quality of platelet concentrates (PCs), we studied in-process recoveries of blood cell counts in pooled PCs derived from four or five buffy coats (BCs) from Biopack Compoflex Systems in Bern (PC-BC/4 or PC-BC/5) and from five BCs from Optipac (Baxter) in Zurich (PC-BC/5). BCs were pooled employing a sterile connecting device and flushing them with 300 mL of platelet additive solution. The pools were centrifuged for 12 min at 500g at 20°C and filtered with PALL's Auto-Stops™ BC-leukocyte removal filter. Automated platelet counting was performed on whole blood donation, on single BC, on pooled BC and in the final product. Four out of 10 PC-BC/4 (=40%) and 29 out of 30 PC-BC/5 (=97%) had a total platelet count of >200 × 109 platelets. Average percentage recoveries in PC compared to the pre-centrifugation BC pools were similar with the Biopack Compoflex and the Optipac systems, 62% and 57% respectively, whereby the absolute platelet count per one donation was similar, i.e. 49.5×109, 55×109 and 53 × 109 in PC-BC/4 and PC-BC/5 from Bern and PC-BC/5 from Zurich. There was a significant positive correlation between the inital number of BCs taken for pooling and the final platelet counts in the PCs. In order to recover a minimal platelet content of 200 × 109 platelets per pooled unit, it is safer to start out with five rather than with four donations unless recoveries during the production steps can be improved.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Pietersz RNI
        • de Korte D
        • Reesink HW
        Storage of whole blood for up to 24 hours at ambient temperature prior to component preparation.
        Vox Sang. 1989; 56: 145-150
        • Gmür J
        • von Felten A
        • Osterwalder B
        Delayed alloimmunization using random single donor platelet transfusions: a prospective study in thrombocytopenic patients with acute leukemia.
        Blood. 1983; 62: 473-479
        • Klüter H
        • Muller-Steinhardt M
        • Danzer S
        • Wilhelm D
        • Kirchner H
        Cytokines in platelet concentrates prepared from pooled buffy coats.
        Vox Sang. 1995; 69: 38-43
        • Wadhwa M
        • Lubenko A
        • Seghatchian MJ
        • Contreras M
        • Dilter P
        • Thorpe R
        Cytokines in platelet concentrates.
        Transfus Sci. 1995; 16: 179-181
        • Aye MT
        • Palmer DS
        • Gilivi A
        • Hashemi S
        Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage.
        Transfus Sci. 1995; 35: 117-124
        • Eisenfeld L
        • Silver H
        • McLaughlin J
        Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood.
        Transfus Sci. 1992; 32: 205-209
        • Bowden R
        • Slichter J
        • Sayers M
        Comparison of filtered leucocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplantation.
        Blood. 1995; 86: 3598-3603
        • Mason A
        • Yoffe B
        • Noonan Ch
        Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance.
        Hepatology. 1992; 16: 36-41
        • Boomgaard MN
        • Joustra-Dijhuis AM
        • Gouwerok CWN
        In vitro evaluation of platelet concentrates, prepared from pooled buffy coats, stored for 8 days after filtration.
        Transfus Sci. 1994; 34: 311-316
        • Kömer K
        • Weihe R
        • Sahlmen P
        Quality of pooled platelet concentates prepared from buffy coats and stored in an additive solution after filtration.
        Ann Hematol. 1995; 70: 97-102
        • Eriksson L
        • Shanwell A
        • Gullikson H
        • Hogman CF
        • Svensson LA
        • Kristensen J
        Platelet concentrates in an additive solution prepared from pooled buffy coats.
        Vox Sang. 1993; 64: 133-138
        • Bertoloni F
        • Rebulla P
        • Maranogin F
        • Sirchia G
        Platelet concentrates stored in synthetic medium after filtration.
        Vox Sang. 1992; 62: 82-86
        • Moroff G
        • Holme S
        • Dabay MH
        Storage of pools of six and eight platelet concentrates.
        Transfus Sci. 1993; 33: 374-378
        • Snyder EL
        • Stack G
        • Napychank P
        • Roberts S
        Storage of pooled platelet concentrates: in vitro and in vivo analysis.
        Transfus Sci. 1989; 20: 390-395
        • Rebulla P
        • Bertolini F
        • Porretti L
        Platelet concentrates from buffy coats: improved conditions for preparation and evaluation in routine clinical use.
        Transfus Sci. 1993; 14: 41-46
        • Hiller J
        • Lubitz B
        • Kühnl P
        • Gutensohn K
        In-line-filtration of platelet concentrates prepared from pooled buffy coats using the PALL-AutoStop BC.
        Infusionsther Transfusionsmed. 1994; 21 (Abstr. A 282): S2
        • Klüter H
        • Dorges I
        • Maas E
        • Wagner T
        • Bartels H
        • Kirchner H
        In-vivo evaluation of random donor platelet concentrates from pooled buffy coats.
        Ann Hematol. 1996; 73: 85-89
        • Klinger HF
        • Josch M
        • Klüter H
        Platelets stored in a glucose-free additive solution or in autologous plasma-an ultrastructural and morphometric evaluation.
        Vox Sang. 1996; 71: 13-20
        • Jungi TW
        • Spycher MO
        • Nydegger UE
        • Barandun S
        Platelet-leucocyte interaction: Selective binding of thrombin-stimulated platelets to human monocytes, polymorphonuclear leucocytes, and related cell lines.
        Blood. 1986; 3: 629-636
        • Krailadsiri P
        • Seghatchian MJ
        Effect of filtration, storage and platelet suspension media on platelet indices.
        Transfus Sci. 1994; 15: 179-183
        • O'Malley T
        • Ludlam CM
        • Fox KAA
        • Elton RA
        Measurment of platelet volume using a variety of different anticoagulant and antiplatelet mixtures.
        Blood Coagulation and Fibrinolysis. 1996; 7: 431-436
        • Goldfinger D
        • McGinnis MH
        Rh-incompatible platelet transfusions—risks and consequences of sensitizing immunosuppressed patients.
        New Engl J Med. 1971; 284: 942-944